Using Medicaid State Drug Utilization Data, this brief presents the 50 most costly drugs before rebates used by the Medicaid program over the January 2014 through June 2015 period. It then examines reasons why these drugs are so costly; explores case studies on opioids, hepatitis C drugs, and the drug Abilify; and considers policy implications.
Health CostsSee more about Health Costs
- view as grid
- view as list
Costly specialty drugs, such as those used to treat Hepatitis C and HIV, are among the most costly medications in state Medicaid programs, chiefly because of their high prices for a course of treatment, according to a new Kaiser Family Foundation analysis of Medicaid’s most costly outpatient drugs. Abilify, an…
Most Americans Worry about Large Number of Zika Cases in U.S. Over Next Year While the public tilts narrowly toward unfavorable views of the Affordable Care Act, presumptive Democratic nominee Hillary Clinton holds a clear advantage on health care issues over presumptive Republican nominee Donald Trump as the 2016 national…
In advance of the Democratic and Republican National Conventions, the July Kaiser Health Tracking Poll examines the role that health care may play in the 2016 presidential election: how important health care is to voters, what health care issues voters would most like to hear the candidates discuss, and which party and candidates voters feel most closely aligned with on health care issues.
The Kaiser Family Foundation will host a web conversation to discuss the drivers of recent and forecasted trends in prescription drug spending and examine how drug prices are set.
In this Wall Street Journal Think Tank column, Drew Altman discusses why adequacy of health coverage will rise as an issue when
the political world moves on from its focus on the Affordable Care Act.
Majorities Across Party Lines Support Investing More Money in Zika Research and Preventing the Virus’ Spread
Democrats More Favorable to ACA in June, Leading to 44% Unfavorable, 42% Favorable Overall Split Majorities of the public say the United States should invest more money in Zika research and in preventing its spread in this country, the latest Kaiser Health Tracking Poll finds. More than seven in 10…
The June Kaiser Health Tracking Poll examines attitudes on the Affordable Care Act and provides an in-depth analysis of two of the biggest health policy stories of the month: the Zika virus outbreak and reports about the rising costs of ACA health insurance premiums.
This Visualizing Health Policy infographic provides details on cancer spending and outcomes in the United States.